Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2012, Article ID 504081, 6 pages
http://dx.doi.org/10.1155/2012/504081
Clinical Study

The Effect of Statins and Other Cardiovascular Medication on Ischemia-Reperfusion Damage in a Human DIEP Flap Model: Theoretical and Epidemiological Considerations

1Department of Plastic, Reconstructive and Hand Surgery, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands
2Department of Pharmacology and Toxicology, Maastricht University Medical Centre, P.O. Box 616, 6200 MD, Maastricht, The Netherlands
3Department of Methodology and Statistics, Maastricht University Medical Centre, P.O. Box 616, 6200 MD, Maastricht, The Netherlands

Received 27 August 2011; Revised 13 November 2011; Accepted 21 February 2012

Academic Editor: Jerzy Kupiec-Węgliński

Copyright © 2012 M. G. W. van den Heuvel et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Bast, “Antioxidant pharmacotherapy,” Drug News and Perspectives, vol. 7, no. 8, pp. 465–472, 1994. View at Google Scholar · View at Scopus
  2. P. Urban, M. Pavlikova, M. Sivonova et al., “Molecular analysis of endoplasmic reticulum stress response after global forebrain ischemia/reperfusion in rats: effect of neuroprotectant simvastatin,” Cellular and Molecular Neurobiology, vol. 29, no. 2, pp. 181–192, 2009. View at Publisher · View at Google Scholar
  3. S. Sharyo, N. Yokota-Ikeda, M. Mori et al., “Pravastatin improves renal ischemia-reperfusion injury by inhibiting the mevalonate pathway,” Kidney International, vol. 74, no. 5, pp. 577–584, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. O. Szarszoi, J. Maly, P. Ostadal et al., “Effect of acute and chronic simvastatin treatment on post-ischemic contractile dysfunction in isolated rat heart,” Physiological Research, vol. 57, no. 5, pp. 793–796, 2008. View at Google Scholar
  5. A. Matsuki, A. Igawa, T. Nozawa et al., “Early administration of fluvastatin, but not at the onset of ischemia or reperfusion, attenuates myocardial ischemia-reperfusion injury through the nitric oxide pathway rather than its antioxidant property,” Circulation Journal, vol. 70, no. 12, pp. 1643–1649, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. B. V. Naidu, S. M. Woolley, A. S. Farivar, R. Thomas, C. Fraga, and M. S. Mulligan, “Simvastatin ameliorates injury in an experimental model of lung ischemia-reperfusion,” Journal of Thoracic and Cardiovascular Surgery, vol. 126, no. 2, pp. 482–489, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Merla, I. N. Daher, Y. Ye, B. F. Uretsky, and Y. Birnbaum, “Pretreatment with statins may reduce cardiovascular morbidity and mortality after elective surgery and percutaneous coronary intervention: clinical evidence and possible underlying mechanisms,” American Heart Journal, vol. 154, no. 2, pp. 391–402, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Wolfrum, A. Dendorfer, M. Schutt et al., “Simvastatin acutely reduces myocardial reperfusion injury In Vivo by activating the phosphatidylinositide 3-kinase/Akt pathway,” Journal of Cardiovascular Pharmacology, vol. 44, no. 3, pp. 348–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. D. G. Wright and D. J. Lefer, “Statin mediated protection of the ischemic myocardium,” Vascular Pharmacology, vol. 42, no. 5-6, pp. 265–270, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Birnbaum, Y. Ye, S. Rosanio et al., “Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury,” Cardiovascular Research, vol. 65, no. 2, pp. 345–355, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Birnbaum, T. Ashitkov, B. F. Uretsky, S. Ballinger, and M. Motamedi, “Reduction of infarct size by short-term pretreatment with atorvastatin,” Cardiovascular Drugs and Therapy, vol. 17, no. 1, pp. 25–30, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Yokota, M. O'Donnell, F. Daniels et al., “Protective effect of HMG-CoA reductase inhibitor on experimental renal ischemia-reperfusion injury,” American Journal of Nephrology, vol. 23, no. 1, pp. 13–17, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Joyce, C. Kelly, D. Winter, G. Chen, A. Leahy, and D. Bouchier-Hayes, “Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates renal injury in an experimental model of ischemia-reperfusion,” Journal of Surgical Research, vol. 101, no. 1, pp. 79–84, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. U. Gottmann, P. T. Brinkkoetter, S. Hoeger et al., “Atorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: possible role for aldose-reductase inhibition,” Transplantation, vol. 84, no. 6, pp. 755–762, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. H. Lee, Y. H. Kim, Y. J. Kim, and B. W. Yoon, “Atorvastatin enhances hypothermia-induced neuroprotection after stroke,” Journal of the Neurological Sciences, vol. 275, no. 1-2, pp. 64–68, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. P. Wood, K. G. Schmidt, J. Melena, G. Chidlow, H. Allmeier, and N. N. Osborne, “The β-adrenoceptor antagonists metipranolol and timolol are retinal neuroprotectants: comparison with betaxolol,” Experimental Eye Research, vol. 76, no. 4, pp. 505–516, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Obata and Y. Yamanaka, “Protective effect of imidaprilat, an angiotensin-converting enzyme inhibitor on ·OH generation in rat myocardium,” Biochimica Et Biophysica Acta, vol. 1472, no. 1-2, pp. 62–70, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Anderson, N. Khaper, A. K. Dhalla, and P. K. Singal, “Anti-free radical mechanisms in captopril protection against reperfusion injury in isolated rat hearts,” Canadian Journal of Cardiology, vol. 12, no. 10, pp. 1099–1104, 1996. View at Google Scholar · View at Scopus
  19. C. Kupatt, H. Habazettl, S. Zahler et al., “ACE-inhibition prevents postischemic coronary leukocyte adhesion and leukocyte-dependent reperfusion injury,” Cardiovascular Research, vol. 36, no. 3, pp. 386–395, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Padrissa-Altés, R. Franco-Gou, O. Boillot et al., “Effect of angiotensin II and bradykinin inhibition in rat reduced-size liver transplantation,” Liver Transplantation, vol. 15, no. 3, pp. 313–320, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R. E. Chavez-Cartaya, G. P. Desola, P. Ramirez-Romero, R. Y. Calne, and N. V. Jamieson, “Ischemia and reperfusion injury of the rat liver: the role of nimodipine,” Journal of Surgical Research, vol. 60, no. 1, pp. 199–206, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Prinz, U. Laufs, K. Gertz et al., “Intravenous rosuvastatin for acute stroke treatment: an animal study,” Stroke, vol. 39, no. 2, pp. 433–438, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. M. G. van den Heuvel, W. A. Buurman, A. Bast, and R. R. W. van der Hulst, “Review: ischaemia-reperfusion injury in flap surgery,” Journal of Plastic, Reconstructive and Aesthetic Surgery, vol. 62, no. 6, pp. 721–726, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Gueler, S. Rong, J. K. Park et al., “Postischemic acute renal failure is reduced by short-term statin treatment in a rat model,” Journal of the American Society of Nephrology, vol. 13, no. 9, pp. 2288–2298, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. V. H. Ozacmak, H. Sayan, A. A. Igdem, A. Cetin, and I. D. Ozacmak, “Attenuation of contractile dysfunction by atorvastatin after intestinal ischemia reperfusion injury in rats,” European Journal of Pharmacology, vol. 562, no. 1-2, pp. 138–147, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Scalia, M. E. Gooszen, S. P. Jones et al., “Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice,” Circulation, vol. 103, no. 21, pp. 2598–2603, 2001. View at Google Scholar · View at Scopus
  27. Y. Ikeda, L. H. Young, and A. M. Lefer, “Rosuvastatin, a new HMG-CoA reductase inhibitor, protects ischemic reperfused myocardium in normocholesterolemic rats,” Journal of Cardiovascular Pharmacology, vol. 41, no. 4, pp. 649–656, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. A. M. Lefer, B. Campbell, Y. K. Shin, R. Scalia, R. Hayward, and D. J. Lefer, “Simvastatin preserves the ischemic-reperfused myocardium in normocholesterolemic rat hearts,” Circulation, vol. 100, no. 2, pp. 178–184, 1999. View at Google Scholar · View at Scopus
  29. M. Chello, P. Mastroroberto, G. Patti et al., “Simvastatin attenuates leucocyte-endothelial interactions after coronary revascularisation with cardiopulmonary bypass,” Heart, vol. 89, no. 5, pp. 538–543, 2003. View at Google Scholar · View at Scopus
  30. P. D. Napoli, A. A. Taccardi, A. Grilli et al., “Chronic treatment with rosuvastatin modulates nitric oxide synthase expression and reduces ischemia-reperfusion injury in rat hearts,” Cardiovascular Research, vol. 66, no. 3, pp. 462–471, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. M. R. Gholami, F. Abolhassani, P. Pasbakhsh et al., “The effects of simvastatin on ischemia-reperfusion injury of sciatic nerve in adult rats,” European Journal of Pharmacology, vol. 590, no. 1–3, pp. 111–114, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. F. Gueler, J. K. Park, S. Rong et al., “Statins attenuate ischemia-reperfusion injury by inducing heme oxygenase-1 in infiltrating macrophages,” American Journal of Pathology, vol. 170, no. 4, pp. 1192–1199, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. J. P. Dillon, A. J. Laing, J. R. Chandler, J. H. Wang, A. McGuinness, and H. P. Redmond, “Pravastatin attenuates tourniquet-induced skeletal muscle ischemia reperfusion injury,” Acta Orthopaedica, vol. 77, no. 1, pp. 27–32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. A. V. Gourine, J. Pernow, D. M. Poputnikov, and P. O. Sjöquist, “Calcium antagonist clevidipine reduces myocardial reperfusion injury by a mechanism related to bradykinin and nitric oxide,” Journal of Cardiovascular Pharmacology, vol. 40, no. 4, pp. 564–570, 2002. View at Publisher · View at Google Scholar
  35. H. Tufan, B. M. Zaki, M. Tecder-Unal, S. R. Erdem, and G. Take, “Angiotensin II captopril cotreatment augments angiogenesis in abdominal skin flap in rats,” Annals of Plastic Surgery, vol. 58, no. 4, pp. 441–448, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Necas, L. Bartosikova, L. Benes et al., “Influence of antioxidant effect of stobadine derivative in condition of kidney ischemia-reperfusion in a pre-clinical experiment (effect in prophylaxis),” Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czechoslovakia, vol. 149, no. 2, pp. 385–388, 2005. View at Google Scholar
  37. M. Chello, A. Anselmi, C. Spadaccio et al., “Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery,” Annals of Thoracic Surgery, vol. 83, no. 4, pp. 1374–1380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Chello, G. Patti, D. Candura et al., “Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery,” Critical Care Medicine, vol. 34, no. 3, pp. 660–667, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Chello, M. Carassiti, F. Agro et al., “Simvastatin blunts the increase of circulating adhesion molecules after coronary artery bypass surgery with cardiopulmonary bypass,” Journal of Cardiothoracic and Vascular Anesthesia, vol. 18, no. 5, pp. 605–609, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. J. K. Plenge, T. L. Hernandez, K. M. Weil et al., “Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction,” Circulation, vol. 106, no. 12, pp. 1447–1452, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. D. A. Pascual, J. M. Arribas, P. L. Tornel et al., “Preoperative statin therapy and troponin T predict early complications of coronary artery surgery,” Annals of Thoracic Surgery, vol. 81, no. 1, pp. 78–83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. G. Patti, M. Chello, V. Pasceri et al., “Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention. Results from the ARMYDA-CAMS (atorvastatin for reduction of MYocardial damage during angioplasty-cell adhesion molecules) substudy,” Journal of the American College of Cardiology, vol. 48, no. 8, pp. 1560–1566, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. V. Pasceri, G. Patti, A. Nusca, C. Pristipino, G. Richichi, and G. D. Sciascio, “Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (atorvastatin for reduction of MYocardial damage during angioplasty) study,” Circulation, vol. 110, no. 6, pp. 674–678, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. K. Mensah, M. M. Mocanu, and D. M. Yellon, “Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten?” Journal of the American College of Cardiology, vol. 45, no. 8, pp. 1287–1291, 2005. View at Publisher · View at Google Scholar · View at Scopus